Maria J. Redondo
Research Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
Articles (21)
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Background. Elevated serum IgA levels have been observed in various autoimmune conditions, including type 1 diabetes (T1D). However, whether children with T1D and elevated serum IgA have unique features has not been studied. We aimed to evaluate the prevalence and characteristics associated with elevated serum IgA at the onset of pediatric T1D. Materials and Methods. We analyzed demographic, clinical, and laboratory data retrospectively collected from 631 racially diverse children (6 months–18 years of age) with T1D who had serum IgA levels measured within 90 days of T1D diagnosis. Univariable and multivariable logistic regression models were used to identify characteristics that were significantly associated with elevated versus normal IgA. Results. Elevated serum IgA was present in 20.3% (128/631) of the children with newly diagnosed T1D. After adjusting for other variables, A1c level ( p = 0.029 ), positive insulin autoantibodies (IAA) ( p = 0.041 ), negative glutamic acid decarboxylase autoantibodies (GADA) ( p = 0.005 ) and Hispanic ethnicity ( p < 0.001 ) were significantly associated with elevated serum IgA. After adjustment for confounders, the odds of elevated serum IgA were significantly increased with positive IAA (OR 1.653, 95% CI 1.019–2.679), higher HbA1c (OR 1.132, 95% CI 1.014–1.268) and Hispanic ethnicity (OR 3.279, 95% CI 2.003–5.359) but decreased with GADA positivity (OR 0.474, 95% CI 0.281–0.805). Conclusions. Elevated serum IgA is present in 20.3% of the children at T1D onset and is associated with specific demographic and clinical characteristics, suggesting a unique pathogenesis in a subset of individuals. Further studies are warranted to investigate the IgA response, its role in T1D pathogenesis, and whether these associations persist over time.
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2022
Year:
2022
Year:
2022
Year:
2021
Year:
2021
Collaborators (8)
Jean W. Hsu
Baylor College of Medicine
Sarah Richardson
Associate Professor in Cellular Biomedicine
University of Exeter
Todd Brusko
Professor/Scientific Director
University of Florida
Åke Lernmark
Lund University
Xiaofan Huang
Baylor College of Medicine
Stephen Rich
Harrison Professor and Founding Director (Emeritus)
University of Virginia
Alberto Pugliese
Chair and Professor
Beckman Research Institute, City of Hope
Jennifer Posey
Assistant Professor
Baylor College of Medicine
Make your next move.
Prepare your application
Review drafts before you send them.